Although several studies have shown a relevant role of CD44 in a reduced number of sarcomas, there is a clear lack of studies in other types of sarcomas such as myxofibrosarcoma, synovial sarcoma, or rhabdomyosarcoma, among others. Here, CD44 is linked to rhabdomyosarcoma.